19 studies found for:    "Klebsiella"
Show Display Options
Rank Status Study
1 Active, not recruiting Risk Factors for Quinolone Resistance Among ESBL Producing Klebsiella Species
Conditions: Quinolone Resistance;   ESBL;   Klebsiella Species;   Infection
Intervention:
2 Unknown  Probiotics for Eradication of Carbapenem Resistant Klebsiella Pneumonia
Conditions: Anti-Biotic Resistance;   Klebsiella Pneumoniae
Interventions: Dietary Supplement: VSL#3;   Drug: Polyethylene glycol
3 Completed Study Evaluating Antibiotic Use in Reducing Vancomycin-Resistant Enterococci and ESBL Producing Escherichia Coli and Klebsiella Pneumoniae in Intensive Care
Conditions: Escherichia Coli Infections;   Klebsiella Infections
Intervention: Drug: vancomycin-resistant enterococci and ESBL
4 Recruiting Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms
Conditions: Escherichia Coli Infections;   Klebsiella Pneumonia
Intervention:
5 Completed Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units
Conditions: Gram-Positive Bacterial Infections;   Escherichia Coli Infections;   Klebsiella Infections
Intervention: Drug: piperacillin-tazobactam
6 Unknown  SDD for Eradicating CRKP Carriage
Condition: Carriers of Carbapenem-resistant Klebsiella Pneumonia
Intervention: Device: Gentamicin and polymyxin E
7 Active, not recruiting Community - Associated Extended-spectrum Beta-lactamases (ESBL)
Conditions: Infection;   E Coli Infections;   Klebsiella Infections;   Proteus Infections
Intervention:
8 Completed Klebsiella Pneumoniae Necrotizing Fasciitis: Clinical and Microbiological Features
Condition: Necrotizing Fasciitis
Intervention:
9 Recruiting Antibiotics for Klebsiella Liver Abscess Study
Condition: Liver Abscess, Pyogenic
Interventions: Drug: Ciprofloxacin;   Drug: Ceftriaxone;   Drug: Trimethoprim/sulfamethoxazole;   Drug: Ertapenem
10 Unknown  A Study Evaluating the Role of Oral Antibiotics in an Aim to Eradicate Carrier State of Carbapenem- Resistant Klebsiella Pneumonia (KPC).
Condition: Patients Diagnosed With Concomitant KPC Associated Disease ,Bacteremia, Pneumonia.
Interventions: Drug: Colistin (Polymyxin E) 100mg x 4/d;   Drug: both medications;   Drug: will not receive PO treatment;   Drug: PO Garamycin 80mg x 4/d
11 Completed Selective Digestive Decontamination in Carriers of Carbapenem-resistant Klebsiella Pneumoniae
Condition: Carriage of Carbapemen-resistant Klebsialle Pneumoniae
Intervention: Drug: Arm #1 :Oral solution and buccal gel of gentamicin and polymyxin E. Arm #2: Placebo.
12 Recruiting Trial to Compare Piperacillin-tazobactam to Meropenem for the Definitive Treatment of Bloodstream Infections Caused by Ceftriaxone Resistant E. Coli or Klebsiella Species.
Condition: Bloodstream Infections
Interventions: Drug: Meropenem;   Drug: Piperacillin-tazobactam combination product
13 Unknown  Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli
Condition: Infections
Intervention: Drug: Colistin
14 Completed The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy
Condition: End-stage Renal Disease
Intervention: Other: renal replacement therapy
15 Enrolling by invitation Community-Onset Bacteremia Due to ESBL Producing E.Coli or K.Pneumoniae in China: Prevalence, Risk Factors and Prognosis
Condition: Community Acquired Infection
Intervention: Other: bacteremia caused by ESBL producing E.coli or K.pneumoniae
16 Completed Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms
Condition: Gram-Negative Bacterial Infections
Intervention: Drug: tigecycline
17 Terminated Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")
Conditions: Benign Airway Disease;   Sarcoidosis;   Wegener's Granulomatosis;   Rhinoscleroma;   Recurrent Respiratory Papillomatosis(RRP)
Intervention: Device: CryoSpray Ablation (tm)
18 Recruiting Detecting Infections Rapidly and Easily for Bacteremia Trial (DIREBT)
Condition: Bacteremia
Intervention:
19 Completed Clinical and Microbiological Outcomes of Infections Due to Carbapenem-Resistant Gram-Negative Bacteria
Condition: Drug Resistance, Microbial
Intervention: Other: None - Observational study

Indicates status has not been verified in more than two years